It was found that interferon-gamma treatment for ovarian cancer caused a reduction of the proliferation-promoting TFs E2F1 and E2F2, at the same time it also increased the inhibiting TFs E2F4 and E2F5[54]. Here, E2F5 is linked to ovarian carcinoma.